首页> 外文期刊>European review for medical and pharmacological sciences. >Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young women
【24h】

Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young women

机译:体重,怀孕和口服避孕药会影响年轻女性的静脉对乙酰氨基酚清除率

获取原文
           

摘要

OBJECTIVES: Because of the extensive variability in paracetamol clearance in young women, published data were pooled with newly collected observations in search of covariates of paracetamol pharmacokinetics (PK) within this specific population. SUBJECTS AND METHODS: PK estimates and clinical characteristics [pregnant, weight, exposure to oral contraceptives (OC)] in young women following IV loading dose (2 g paracetamol) were pooled, using a non-compartmental linear disposition model in individual time-concentration profiles. Data were reported by median and range. Rank correlation was used to link clearance (l/h) to weight, Mann Whitney U test to compare clearance (l/h.m-2) between subgroups (pregnant, OC exposure). Finally, a multiple regression model with clearance (l/h) in all women and all non-pregnant women was performed. RESULTS: Based on 73 paracetamol PK estimates, a 8-fold variability in clearance (range 7.1-62.2 l/h) was documented, in part explained by a correlation (r2=0.36) between clearance (l/h) and weight. Clearance (l/h and l/h.m-2) and distribution volume (l) at delivery (n=36) were higher compared to non-pregnant observations. In non-pregnant women, women on OC (n=20) had a higher paracetamol clearance (l/h.m-2) compared to women (n=17) not on OC (p = 0.023). Weight (p = 0.0043) and pregnancy (p = 0.02) were independent variables (r=0.56) of paracetamol clearance (l/h). In non-pregnant women, weight (p = 0.009) and OC exposure (p = 0.03) were independent variables (r=0.51). CONCLUSIONS: Weight, pregnancy and OC result in higher clearance of IV paracetamol in young women. Besides compound specific relevance, these findings also unveil covariates of drug metabolism in young women.
机译:目的:由于年轻女性对乙酰氨基酚清除率的广泛差异,因此将发表的数据与新收集的观察结果合并,以寻找该特定人群中对乙酰氨基酚药代动力学(PK)的协变量。研究对象和方法:使用非房间隔线性处置模型,在个体时间集中,汇总静脉注射负荷剂量(2 g对乙酰氨基酚)后年轻女性的PK估计值和临床特征[怀孕,体重,口服避孕药(OC)]个人资料。数据按中位数和范围报告。等级相关性用于将清除率(l / h)与体重相关联,Mann Whitney U检验用于比较各亚组之间的清除率(l / h.m-2)(怀孕,OC暴露)。最后,对所有妇女和所有未怀孕妇女进行了具有清除率(l / h)的多元回归模型。结果:根据对乙酰氨基酚PK的73个估计值,清除率(范围7.1-62.2 l / h)记录了8倍的变化,部分解释为清除率(l / h)与重量之间的相关性(r2 = 0.36)。与非怀孕观察相比,分娩时的通透性(l / h和l / h.m-2)和分布体积(l)(n = 36)更高。在未怀孕的妇女中,与未服用OC的妇女(n = 17)相比,服用OC(n = 20)的妇女对乙酰氨基酚清除率(l / h.m-2)更高。体重(p = 0.0043)和妊娠(p = 0.02)是对乙酰氨基酚清除率(l / h)的独立变量(r = 0.56)。在未怀孕的妇女中,体重(p = 0.009)和OC暴露(p = 0.03)是独立变量(r = 0.51)。结论:体重,妊娠和OC导致年轻女性对乙酰氨基酚的清除率更高。除了化合物的特定相关性外,这些发现还揭示了年轻女性药物代谢的协变量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号